Altaviz

Executive Summary

Altaviz is a private medical device company headquartered in Irvine, California, specializing in sustained-release drug delivery technologies with a primary focus on ophthalmic applications. Founded in 2018, the company operates as a partner and service provider to pharmaceutical and medical device firms, leveraging its proprietary delivery frameworks to enable precision drug release across various therapeutic areas. By offering design, development, and commercialization services, Altaviz addresses a critical need for long-acting therapies that improve patient compliance and treatment outcomes, particularly in ophthalmology where chronic conditions like glaucoma and macular degeneration require frequent dosing. The company's business model as a technology enabler positions it to capture value across multiple drug programs without bearing the full risk of drug development, making it an attractive collaborator for larger pharma partners. With its expertise in sustained release, Altaviz is well-placed to benefit from the growing demand for innovative drug delivery solutions that reduce injection frequency and enhance therapeutic efficacy.

Upcoming Catalysts (preview)

• Q4 2026Announcement of a strategic partnership with a major ophthalmic pharmaceutical company40% success
• Q3 2026Completion of a Series A funding round50% success